Organigram Holdings Inc. is pleased to announce the release of a new addition to its cannabis oil offerings: a pure CBD edible oil, Shubie. This pure CBD product is a first for Organigram, complementing the company’s existing line of medical cannabis oil products.
Cannabinoids are the chemical compounds unique to cannabis that act upon the human body’s cannabinoid receptors. There are over 80 known cannabinoids present in the cannabis plant, each with varying effects. CBD (or Cannabidiol) is the second most prevalent cannabinoid in cannabis. Research has shown that CBD provides a therapeutic or calming effect without contributing to the “high” associated with Tetrahydrocannabinol (or THC), the psychoactive compound in cannabis.
“Patients are unique and require different products that help in different ways” says Greg Engel, CEO, Organigram. “As a result, we recognize the need to continually innovate and enhance both our processes and products. Today we are proud to extend our product offering and introduce Shubie Cannabis Oil as an option for patients who will benefit from its pure CBD formulation.”
“Over the past year, we have a seen a surge in interest from both physicians and patients in CBD-based products that help manage the symptoms of a number of chronic conditions, including pain,” adds Ray Gracewood, Chief Commercial Officer, Organigram. “We’ve taken the time to produce a real and reliable solution that ensures our patients and their needs are our number one priority.”
Like the other oils in the Organigram line up, Shubie was named for an iconic Atlantic Canadian waterway. The Shubenacadie River, or “Shubie” (pronounced “shoobee”) is a magnetic artery in Nova Scotia. With jaw-dropping tidal swells, witnessing the rush of water down the cliff-lined canal is an invigorative, restorative experience.